Clopidogrel as the standard of care for elective PCI: Findings from the ALPHEUS
Watch the video and get to know more on ALPHEUS trial. Since Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and can affect the long-term prognosis of patients, then stronger platelet inhibition could potentially lower these events and make the PCI procedure safer.
Login to access this and all our premium content
New to Campus Sanofi? Register to access all our Content